| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 76.2708 | 71 |
| GSM780708 | Untreated after 4 days (C2_1) | 110.032 | 77 |
| GSM780709 | Untreated after 4 days (C3_1) | 131.587 | 79 |
| GSM780719 | Untreated after 4 days (C1_2) | 74.4089 | 70 |
| GSM780720 | Untreated after 4 days (C2_2) | 123.168 | 78 |
| GSM780721 | Untreated after 4 days (C3_2) | 125.857 | 78 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 76.4661 | 71 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 93.4585 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 86.9418 | 73 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 84.7364 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 109.328 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 106.014 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 170.097 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 114.242 | 77 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 132.513 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 157.375 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 107.972 | 76 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 125.688 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 69.7791 | 69 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 64.6135 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 100.488 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 81.7818 | 72 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 91.7124 | 74 |